Annovis Bio, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported net loss was USD 56.2 million compared to USD 25.33 million a year ago. Basic loss per share from continuing operations was USD 6.23 compared to USD 3.1 a year ago.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.875 USD | +2.15% | +14.92% | -63.13% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-63.07% | 75.18M | |
+18.52% | 125B | |
+14.35% | 109B | |
-2.76% | 24.74B | |
+2.71% | 22.67B | |
-9.95% | 18.14B | |
-41.48% | 16.67B | |
-12.14% | 16.64B | |
+0.01% | 13.45B | |
+23.10% | 11.32B |
- Stock Market
- Equities
- ANVS Stock
- News Annovis Bio, Inc.
- Annovis Bio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023